Forms & Information

Ask An Expert

Ask an expert Hepatitis C and liver cancer

“I’ve been diagnosed with hepatitis C. What is my risk of developing liver cancer? Should I be tested for it?”

Ask an expert: Am I at risk for colorectal cancer? What can I do to lower my risk?

Everyone is at some risk for developing cancer of the colon or rectum, collectively known as colorectal cancer. And everyone can take steps to reduce his or her risk. In fact, about 90 percent of colorectal cancers may be preventable.

Ask an expert: Can liver cancer run in the family?

Q: “Is liver cancer hereditary? Does my mother’s recent diagnosis mean that I have a higher chance of getting it, too?”

Ask an expert: I've finished my cancer treatment. Now what?

Q: “I finally completed my cancer treatment, and I thought I would be elated, but instead I feel a little bit lost. I'm so used to focusing on the fight – what should I be doing now that it's over?”

Ask an expert: What is islet cell cancer?

Islet cell cancer is a relatively rare type of pancreatic cancer that develops in the islet cells – so called because the cells cluster together like small islands throughout the pancreas.

Ask an expert: What you should know about polyps

Todd Crocenzi, M.D., answers frequently asked questions about polyps. Dr. Crocenzi is a medical oncologist and director of the Providence Gastrointestinal Cancer Research Program at Providence Cancer Center.

Ask an expert: What’s the future outlook for pancreatic cancer treatment?

For a long time, the news for people with pancreatic cancers hasn’t been great. But we’re starting to get the sense that things are finally changing.

Ask an expert: Where does pancreatic cancer develop?

The pancreas is a 6-inch-long gland that sits between the stomach and the spine. Different types of pancreatic cancer develop in different parts of the pancreas.

Cancer trials are a vital, yet often overlooked, treatment option

It’s more important than ever for referring primary care physicians to work in concert with clinical trialists before initiating therapy. These partnerships enhance the understanding of clinical trials and ensure that more patients gain access to these advanced therapies. – By Keith S. Lanier, M.D., researcher and medical oncologist

Cancers rise with HPV, but treatments keep pace

Human papilloma virus has contributed to the alarming increase in oral, head and neck cancers in younger patients. But these cancers also carry a better prognosis than their non-HPV-related counterparts, allowing for less aggressive treatment options. – By R. Bryan Bell, M.D., D.D.S., FACS, surgeon

Chest Watch Event - Twitter Highlights

Bringing science education to life, Providence School Outreach hosted more than 125 Portland-area high school students for a live “Chest Watch” surgery as Dr. John Handy, thoracic surgeon with Providence Thoracic Oncology Program, performed an initial lung thoracoscopy and then lobectomy on a life-long smoker.

Prostate cancer immunotherapy moves forward

New studies that combine immunotherapy with other agents are stimulating an immune response in men with metastatic prostate cancer. – By Brendan Curti, M.D., medical director, Providence Genitourinary Oncology Research

Providence Cancer Center experts share insights, summer 2012

Our cancer specialists and researchers have been active on an international scale in 2012, and many are slated to appear at conferences into the fall. Here’s a partial list of who’s presenting and publishing.

What to expect when you’re prepping (for your colonoscopy)

How many of you cringe at scheduling a colonoscopy because the procedure (for which you’re knocked out) is a total drag? Yeah, we didn’t think so. It’s not the procedure itself that gets you in the gut – it’s the dreaded, much-maligned prep. Find out what works and what doesn't from Ken Flora, M.D., regional co-medical director of Providence Digestive Health Institute.

Forms Instructions

Ask an expert: Can I develop skin cancer even if my skin doesn’t burn?

I get a lot of questions about burning, tanning, skin color and skin cancer, and no matter which way you look at this question, the answer remains the same: Yes, you can still get skin cancer.

Ask an expert: What are the top risk factors for skin cancer?

Q: “I love being out in the sun, but I have light skin that tends to burn and freckle. Should I be worried about skin cancer? What are the main risk factors? How can I reduce my risks?”

Bringing out the big guns to kill cancer

Technology opens new doors for combining radiation and immunotherapy.

Cancer case summaries

Data collected by Providence’s Regional Cancer Registry provide detailed information about key tumor types, as treated at our major Providence hospitals in Oregon.

Cancer Conference Instructions

Information for Healthcare Professionals on how to access Providence Cancer Conferences.

Fat is good, bagels are bad

Some (Mediterranean) principles to eat by.  When it comes to preventing or managing obesity, heart disease, cancer and many other health problems, good food is often your best medicine.

Prostate cancer research gets a boost

Prostate cancer, once it spreads to lymph nodes and bones, generally is not curable. But basic and clinical researchers at Providence are working on this challenge.

Strategies: Beating back cancer, cell by cell

Providence spinout UbiVac is using immunotherapy to help cure cancer

Two new reasons to get serious about sunscreen

By Brendan Curti, M.D., medical oncologist, director of the Providence Immunotherapy Program at Providence Cancer Center and director of...

Proprietary Health Article

Advances in prostate cancer immunotherapy at Providence

As knowledge about the immune system explodes, so does the potential of innovative treatments. – By Brendan Curti, M.D., medical director, Providence Genitourinary Oncology Research

Ask an expert: Immunotherapy and Providence's cancer warriors

For more than 20 years, Providence Cancer Center scientists in Portland have been quietly building international recognition for their pioneering research in immunotherapy, a field that is now leading to new treatments, and possibly cures, for cancer.

Breast cancer chemoprevention in the spotlight again

After a tentative start, chemopreventive therapies might return to the forefront.  A recent international study reports promising results. – By Ali Conlin, M.D., medical oncologist

Breast cancer classification turns to gene expression

Will gene-expression profiling soon become the new way to classify breast cancer? New research shows this profiling is gaining momentum. – By Ali Conlin, M.D., medical oncologist

Can an exercise program ease chemotherapy fatigue?

A study examines the effects of exercise for cancer patients starting chemotherapy. – By Anupama Kurup, M.D., medical oncologist

Casting a light on lumpectomy

An optical fiber may transform how small breast lesions are located and removed.

Colorectal cancer risks: tobacco, obesity and inactivity

Once again, tobacco use is firmly established as a cause of cancer, this time, colorectal cancer. – By Todd S. Crocenzi, medical oncologist and researcher

Colorectal cancer screening: back to the basics

Amid controversies over complex screening options, stool-based testing can offer a simple solution today. – By Todd S. Crocenzi, M.D., medical oncologist and researcher

Crizotinib may be a powerful weapon against lung cancer

In early studies, nearly 90 percent of patients with an ALK genetic mutation responded to the drug, which targets metastatic non-small cell lung cancer. – By Rachel E. Sanborn, M.D., co-medical director, Providence Thoracic Oncology Program

Early-phase clinical trials open new opportunities

Providence's involvement with the International Immuno-Oncology Network, along with other early-phase studies, is broadening treatment options for patients with advanced cancers. – By Rachel E. Sanborn, M.D., co-medical director, Providence Thoracic Oncology Program

Hematologic Cancer Research at Providence Cancer Center

The immune system has immense potential to destroy tumors while sparing normal tissue. Developing new immuno-oncology therapies for blood-related cancers is the primary focus of the Hematologic Malignancies Program at Providence Cancer Center.

How “Transitions” helps breast cancer patients feel WHOLE again

"Transitions" at PSVMC offers counseling and products to aid women on their journey through treatment. A social worker and a nurse navigator act as coaches and guides. Donated wigs help patients look and feel better.

Jenny Conlee battles back from breast cancer

Two years ago, fans were saddened to learn that The Decemberists’ keyboardist was diagnosed with stage III breast cancer. How’s she doing today?

Living Well

A guide to how our team can help you live well through cancer and beyond.

New system therapies emerge for liver cancer

A study at Providence Cancer Center builds on the success of sorafenib. – By Todd S. Crocenzi, medical oncologist and researcher

Promising developments in lung cancer screening

A large national study reports that suspicious findings were three times greater with CT scans than with chest X-rays. – By Rachel E. Sanborn, M.D., medical oncologist

Prostate cancer and PSA: Should your patient get screened?

Oncologist and researcher Brendan Curti, M.D., discusses the benefits and limitations of the prostate-specific antigen test – and which patient groups can benefit from annual screening.

Providence Cancer Center integral to rapid progress of new cancer therapies

"In the past five years, we have seen more progress in cancer therapy than in the previous 100 years." – Walter J. Urba, M.D., Ph.D., research director, Providence Cancer Center and Earle A. Chiles Research Institute. Dr. Urba shared this powerful, inspiring statement during the May 25 Creating Hope Dinner to benefit continued research at Providence Cancer Center. This record-breaking event raised nearly $1 million for new research efforts, and we’re pleased to share important updates about our work.

Providence Cancer Center's global reach, fall 2011

Two of Providence Cancer Center’s top researchers were invited to China in October to talk about advances in immunotherapy, while others spoke in Italy and Chile. Here’s a partial list of our specialists’ appearances and publications.

Providence inScope: Breaking melanoma's grip

The September issue of Providence inScope, our clinical news magazine, examines a combination therapy that may hold promise for people with advanced melanoma.

Providence inScope: Treating brain aneurysms

The November issue of Providence inScope, our clinical news magazine, examines a new stent to repair complex brain aneurysms; plus, treating HPV-related oral cancers.

Providence Stop-Smoking Resources

If you smoke, one of the most important steps you can take to improve your health is to quit smoking. Providence Health & Services supports you in this effort. The resources below can help you stop smoking for good.

Providence study points to a new treatment option for advanced melanoma

An ongoing Providence Cancer Center study combining two immunotherapy treatments has achieved a 77 percent disease-control rate in patients with advanced melanoma.

Studies bring clarity to combination therapies for colorectal cancer

Recent trials have brought some consistency back to integrating EGFR antagonists in the treatment of metastatic colorectal cancer. – By Todd S. Crocenzi, M.D., medical oncologist and researcher

Studying apricoxib with erlotinib for lung cancer

A trial testing apricoxib with erlotinib showed longer survival in younger patients with metastatic lung cancer, but failed to meet its goal. – By Rachel E. Sanborn, M.D., medical oncologist

Studying statin chemoprevention in colon cancer patients

A clinical trial examines whether statins will inhibit a recurrence in patients with resected stage I or II colorectal cancer. – By Anupama Kurup, M.D., medical oncologist

Survival improves for colon cancer liver metastases

Progression to stage IV colorectal cancer was once a dismal prognosis, but advances in therapies and surgical techniques have changed the odds. – Ronald F. Wolf, M.D., surgical oncologist

Vitamin D and breast cancer: Is there a link?

Studies have provided conflicting results, but here’s what we know so far. – By Ali Conlin, M.D., medical oncologist

What lies ahead for OHNC treatment

From validating biomarkers to exploring tumor-derived vaccines, research is exploring the therapies of the future for oral, head and neck cancers. – R. Bryan Bell, M.D., D.D.S., FACS, surgeon

Where doctors come to heal themselves

The significance of the Kleenex boxes placed on every tabletop isn’t apparent at first. But 15 minutes into this lunchtime gathering of doctors, nurses and a host of other health care workers, the reason becomes clear.

Whole genome sequencing: Personalized medicine’s next step

We’re transitioning from single gene mutation testing to mapping and decoding whole genomes – a leap forward in treatment planning. – Carlo Bifulco, M.D, pathologist

Recommended Resource

American Cancer Society

American Cancer Society’s home page with links to all types of cancer, symptoms, treatment options, statistics trials and ways to contribute. 

Cancer Support Services: Financial Resources

Find a list of recommended websites from our Cancer Support Services social workers.

Cancer Support Services: General Information

Recommended websites providing general information on cancer topics.

National Cancer Institute

National Cancer Institute home page with links to all cancer topics, clinical trial information, statistics, research and treatment information.